Substance Use Disorders on the Rise for Survivors of Specific Cancers

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, Jan. 12, 2024 -- The prevalence of substance use disorder (SUD) seems to be elevated among survivors of certain types of cancer, according to a study published online Jan. 11 in JAMA Oncology.

Katie F. Jones, Ph.D., from VA Boston Healthcare System, and colleagues describe cancer type-specific prevalence of SUD among adult cancer survivors in a cross-sectional study using data from the annually administered National Survey on Drug Use and Health for 2015 through 2020. The analyses included 6,101 adult cancer survivors.

The researchers found that the prevalence of active SUD was 3.83 percent among lifetime cancer survivors. The prevalence of SUD was highest in survivors of head and neck cancer (including mouth, tongue, lip, throat, and pharyngeal cancers), esophageal and gastric cancer, cervical cancer, and melanoma (9.36, 9.42, 6.24, and 6.20 percent, respectively). The most common SUD was alcohol use disorder overall (2.78 percent) and in survivors of head and neck cancer, cervical cancer, and melanoma. Cannabis use disorder was the most prevalent SUD in survivors of esophageal and gastric cancers (9.42 percent). The overall prevalence of active SUD was similar among respondents diagnosed with cancer in the past 12 months to that in the lifetime cancer survivor cohort (3.81 percent). Active SUD was higher in head and neck and cervical cancer survivors (18.73 and 15.70 percent, respectively).

"Findings of this study highlight subpopulations of adult cancer survivors who may benefit from efforts to integrate cancer and addiction care," the authors write.

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-13 22:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords